Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance / Mariottini A, Repice AM, Barilaro A, Massacesi L. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-3478. - ELETTRONICO. - 43:(2022), pp. 4095-4097.

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance

Mariottini A
;
Repice AM;Barilaro A;Massacesi L
2022

Abstract

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
2022
43
4095
4097
Mariottini A, Repice AM, Barilaro A, Massacesi L
File in questo prodotto:
File Dimensione Formato  
Anti‑SARS‑Cov2 vaccination at the time of the COVID‑19 pandemic.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 538.17 kB
Formato Adobe PDF
538.17 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1259130
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact